X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


最新的帖子

九月 02, 2020

SARS-CoV-2 Vaccines – Alternative Vial Components

The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
Whitney Winters

Whitney Winters

Sr. Director, Strategic Marketing, Containment Systems

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • 以前的博客
    Bettine Boltres presents at PDA Webinar

    八月 24, 2020

    How to Include Elastomers in the Nitrosamine Risk Assessment

    Bettine Boltres

    Dr. Bettine Boltres

    Principal Scientific Affairs, Packaging & Delivery Systems

    Stoppers

    八月 03, 2020

    Elastomer Stoppers – Performance

    Mary Tan

    Mary Tan

    Specialist, Scientific Affairs, Jurong

    Vial Container Closures

    十二月 23, 2019

    Data-Driven Container Closure System Optimization

    Anthony Bucci

    Anthony Bucci

    Senior Research Engineer, Insights Lab

    Load more